+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiotensin II Receptor"

From
From
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Acute Ischemic Stroke Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Telmisartan Market Report and Forecast 2024-2032 - Product Thumbnail Image

Telmisartan Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Angiotensin II Receptor market is a segment of the Cardiovascular Drugs market. It is composed of drugs that target the Angiotensin II Receptor, a protein found in the body that plays a role in regulating blood pressure. These drugs are used to treat hypertension, congestive heart failure, and other cardiovascular diseases. They work by blocking the action of Angiotensin II, which helps to reduce blood pressure. The Angiotensin II Receptor market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. These companies have developed a range of drugs that target the Angiotensin II Receptor, including ACE inhibitors, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors. Show Less Read more